Medical science is completely upended by a startling study that suggests Alzheimer's may begin in the body rather than the brain.

Alzheimer's is typically described as a brain-first illness that causes memory loss, neuronal damage, and the accumulation of misfolded proteins. However, a recent genomic analysis suggests a very different beginning.

Inflammation in "barrier" organs like the skin, lungs, or gut may be the initial aetiology of Alzheimer's disease rather than the brain. Research indicates that this could occur decades before someone misses their way home or forgets a name.

If this analysis is accurate, it may also help explain why Alzheimer's medications have so frequently failed, a problem that has long concerned families and researchers.

Once the disease is well established, many treatments target tau or amyloid. According to this new research, we might be treating the smoke when the match was set someplace else a long time ago, therefore we might be coming late to the fire.

Alzheimer's risk and inflammation

This framing of the "whole body" is not entirely new. An increasing number of research have suggested a connection between dementia risk and inflammation and immunological activation.

The magnitude and specificity are novel in this case. The researchers discovered that a surprisingly large portion of the signal is located outside the brain after tracking the genetics of Alzheimer's risk across a variety of tissues and cell types.

The researchers assembled a massive dataset under the direction of François Cunha at the Novo Nordisk Foundation Center for Basic Metabolic Research in Denmark.

They used the European Alzheimer and Dementia Biobank to compare genetic data from about 85,000 individuals with Alzheimer's and around 485,000 individuals without the disease. The researchers then went one step further and examined gene activity in almost 5 million individual cells from 40 body regions and 100 brain regions.

This allowed the researchers to pose a straightforward query: where in the body are the genes linked to the risk of Alzheimer's disease? They concentrated on about 1,000 genes that have variations known to increase the incidence of Alzheimer's.

Low brain signals associated with risk genes

The twist that caused the researchers to halt was that several of these risk genes had very low activity in brain cells but much higher activity in other organs, such as the skin, lungs, digestive system, spleen, and immune cells in the blood.

Because the brain signal appeared so feeble, Cunha said he first thought there was a mistake. However, the trend persisted once the analyses were repeated and expanded.

A significant portion of the hereditary risk for Alzheimer's appears to be "spoken" loudest in the immune system and in organs that interact with the environment on a regular basis. This is significant because a large number of these genes are part of the immune system, which regulates inflammation.

Barrier tissue inflammation

Numerous risk genes were found to be particularly common in barrier tissues such as the skin, lungs, and gut. Every day, these tissues are on the front lines, reacting to allergies, poisons, pathogens, and irritation. They are designed to trigger inflammatory reactions, which can occasionally become prolonged or heightened.

The consequence is intriguing: genetic variations may affect how strongly an individual's body responds to inflammatory stimuli or infections in these tissues, as well as whether or not that immunological activity eventually spreads to the brain.

According to this theory, an individual with inherited risk variations may be more susceptible to a "chain reaction." triggered by anything that doesn't appear to be neurological at all, like an attack of intestinal irritation or a lung illness. Years may pass before the damage manifests as cognitive loss.

The connection between Alzheimer's and inflammation

Age-related timing was one aspect that the scientists found particularly noteworthy. These Alzheimer's-linked mutations were most prevalent between the ages of 55 and 60. This implies that midlife might be a particularly vulnerable time when inflammation is more likely to have long-term effects.

This is consistent with previous findings. Men who had greater levels of inflammatory markers in their blood in their late 50s had a higher chance of developing Alzheimer's decades later, according to a long-running study conducted in Hawaii.

According to Cunha, a major inflammatory event in your late 50s, such a viral lung infection, may initiate processes that manifest as dementia 20 or 30 years later. Additionally, he emphasised that a significant portion of the riddle is still unanswered and that the process is still unclear.

Genes do not determine fate.

Similar signals have been circulated by other researchers. Recently, Rezanur Rahman of the QIMR Berghofer Medical Research Institute in Australia discovered that variations associated with Alzheimer's disease also appear to concentrate in the skin and lungs.

However, he warned that genetic connection by itself does not demonstrate that such genes are functionally responsible for illness. To put it another way, the pattern is intriguing but not yet conclusive. That's a crucial reality check. Although a notion is strengthened by this analysis, the case is not resolved.

Changing the focus of Alzheimer's disease to inflammation

Getting the Alzheimer's field to significantly broaden its focus is currently a difficulty, according to Cunha. He explains how amyloid has dominated conference discussions for decades, to the extent that anything that deviates from that framework can be written off as "not really Alzheimer's."

It makes sense to have that kind of scientific inertia. Changing your mental model is difficult if you've been chasing a certain mechanism for thirty years. However, the new information supports an emerging theory that suggests Alzheimer's may be a lengthy, gradual systemic process rather than a brain-only condition, with the brain being the final site of damage.

If such is the case, the most crucial years for prevention may occur long before the first memory test appears aberrant.